Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin | Zendy

Charles J. Glueck | Zendy; P. Wang | Zendy; Naila Goldenberg | Zendy; Luann Sieve-Smith | Zendy

AI Assistant Blog Pricing

Open Access

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

Author(s) -

Charles J. Glueck,

P. Wang,

Naila Goldenberg,

Luann Sieve-Smith

Publication year - 2002

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/17.11.2858

Subject(s) - polycystic ovary , medicine , metformin , pregnancy , obstetrics , live birth , gynecology , gestational diabetes , odds ratio , abortion , gestation , diabetes mellitus , endocrinology , insulin resistance , biology , genetics

We sought to determine whether metformin, which had facilitated conception in 72 oligoamenorrhoeic women with polycystic ovary syndrome (PCOS), would safely reduce the rate of first trimester spontaneous abortion (SAB) and increase the number of live births without teratogenicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog